ABVC - CIK 0001173313
ABVC BIOPHARMA, INC. has filed 780 documents with the SEC between 2002 and 2026. The most frequent type is major company event (250 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2023-08-02 | 2023-08-02 |
| Major company event | 8-K | 2023-07-31 | 2023-07-31 |
| Prospectus supplement | 424B5 | 2023-07-31 | - |
| Major company event | 8-K | 2023-07-27 | 2023-07-27 |
| Major company event | 8-K | 2023-07-24 | 2023-07-24 |
| Major company event (amended) | 8-K/A | 2023-07-14 | 2023-05-26 |
| Major company event | 8-K | 2023-07-07 | 2023-07-07 |
| Major company event | 8-K | 2023-06-23 | 2023-06-23 |
| Proxy statement | DEF 14A | 2023-06-21 | 2023-07-07 |
| Major company event | 8-K | 2023-06-15 | 2023-06-15 |
| 424B4 | - | 2023-06-12 | - |
| Major company event | 8-K | 2023-06-09 | 2023-06-09 |
| Major company event | 8-K | 2023-06-09 | 2023-06-09 |
| EFFECT | - | 2023-06-08 | - |
| S-1/A | - | 2023-06-08 | - |
| Company correspondence | CORRESP | 2023-06-07 | - |
| S-1/A | - | 2023-06-07 | - |
| Company correspondence | CORRESP | 2023-06-01 | - |
| S-1/A | - | 2023-06-01 | - |
| PRE 14A | - | 2023-05-31 | 2023-05-31 |
| Major company event | 8-K | 2023-05-26 | 2023-05-26 |
| 424B4 | - | 2023-05-22 | - |
| 424B3 | - | 2023-05-22 | - |
| Quarterly report | 10-Q | 2023-05-15 | 2023-03-31 |
| SEC correspondence | UPLOAD | 2023-05-11 | - |
| S-1/A | - | 2023-05-10 | - |
| Company correspondence | CORRESP | 2023-05-10 | - |
| SEC correspondence | UPLOAD | 2023-05-03 | - |
| EFFECT | - | 2023-05-01 | - |
| EFFECT | - | 2023-05-01 | - |
| POS AM | - | 2023-04-26 | - |
| POS AM | - | 2023-04-26 | - |
| IPO registration | S-1 | 2023-04-24 | - |
| Major company event | 8-K | 2023-04-24 | 2023-04-24 |
| Proxy statement | DEF 14A | 2023-04-14 | 2023-04-24 |
| PRE 14A | - | 2023-04-04 | 2023-04-03 |
| Major company event (amended) | 8-K/A | 2023-04-03 | 2023-03-31 |
| Major company event | 8-K | 2023-03-31 | 2023-03-31 |
| Annual report | 10-K | 2023-03-31 | 2022-12-31 |
| D | - | 2023-03-02 | - |
| Major company event | 8-K | 2023-02-24 | 2023-02-24 |
| Major company event | 8-K | 2023-02-16 | 2023-02-16 |
| 424B4 | - | 2022-11-15 | - |
| 424B3 | - | 2022-11-15 | - |
| Quarterly report | 10-Q | 2022-11-14 | 2022-09-30 |
| Major company event | 8-K | 2022-10-21 | 2022-10-21 |
| Major company event | 8-K | 2022-09-13 | 2022-09-12 |
| Major company event | 8-K | 2022-09-09 | 2022-09-04 |
| 424B4 | - | 2022-08-25 | - |
| 424B3 | - | 2022-08-25 | - |